Search - tctmd.com

Displaying 381 - 400 of 1726

Sort: Relevancy | Date

Presentation TCT 2019

Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions

Presenter: Sandeep Basavarajaiah

September 27, 2019

Presentation TCT 2019

Very Late Stent Failure: Frequency and Predictive Factors

Presenter: Mahesh Madhavan

September 27, 2019

Presentation TCT 2019

Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials

Presenter: Bruno Scheller

September 27, 2019

Presentation TCT 2019

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Intravascular Imaging Insights

Presenter: Giulio Guagliumi

September 27, 2019

Presentation TCT 2019

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Pathologic Insights

Presenter: Aloke Finn

September 27, 2019

Presentation TCT 2019

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

Preview From the Upcoming Ischemia Trial

Presenter: David Maron

September 27, 2019

Presentation TCT 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presenter: Jean Fajadet

September 27, 2019

Presentation TCT 2019

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Presenter: Fazila Malik

September 27, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Presenter: Adrian Magee

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Ultrathin Orsiro: Where It Can Go

Presenter: Steven Yakubov

September 26, 2019

Presentation TCT 2019

FDA Pivotal Clinical Trial Design and Beyond

Presenter: Ori Ben-Yehuda

September 26, 2019

Presentation TCT 2019

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

Presenter: Sandeep Basavarajaiah

September 26, 2019

Presentation TCT 2019

A Personal Perspective: Why I Choose Orsiro in STEMI

Presenter: Juan Fernando Iglesias

September 26, 2019

Presentation TCT 2019

Real-World Data From EASTBOURNE to TRANSFORM Trials

Presenter: Bernardo Cortese

September 26, 2019

Presentation TCT 2019

First Experience With FDA-Approved Orsiro in the USA

Presenter: Farouc Jaffer

September 26, 2019

Presentation TCT 2019

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Presenter: Alexandre Abizaid

September 26, 2019

Presentation TCT 2019

Why SEB Should Be Safer: Insights From Preclinical Study

Presenter: Aloke Finn

September 26, 2019

Advertisement

Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions

Very Late Stent Failure: Frequency and Predictive Factors

Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Intravascular Imaging Insights

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Pathologic Insights

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Preview From the Upcoming Ischemia Trial

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Ultrathin Orsiro: Where It Can Go

FDA Pivotal Clinical Trial Design and Beyond

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

A Personal Perspective: Why I Choose Orsiro in STEMI

Real-World Data From EASTBOURNE to TRANSFORM Trials

First Experience With FDA-Approved Orsiro in the USA

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Why SEB Should Be Safer: Insights From Preclinical Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content